U.S. Basic Materials Stock News

NYSE:SMG
NYSE:SMGChemicals

Is Scotts Miracle-Gro (SMG) Refocus on U.S. Consumer Poised to Reshape Its Investment Narrative?

Earlier this week, Scotts Miracle-Gro reported that strong demand in its core U.S. Consumer segment coincided with progress on innovation, acquisitions, cost-saving measures, and supply chain enhancements, alongside the divestiture of its Hawthorne business to streamline operations. This combination of refocusing on the core consumer franchise and exiting Hawthorne is drawing attention to how a leaner structure could affect earnings quality and operational consistency. Now, we’ll explore how...
NasdaqGS:FRVO
NasdaqGS:FRVORenewable Energy

Fervo Energy (FRVO) Could Be 46% Undervalued Following Sawtooth 7 Progress

Fervo Energy (FRVO) is back in focus after reporting that Sawtooth 7, its ninth Cape Station Phase II well, matched its fastest 21 day drilling timeline in a significantly deeper and hotter resource. See our latest analysis for Fervo Energy. The latest drilling milestone comes after a volatile spell for Fervo Energy’s stock, with a 30 day share price return down 32.45% and a year to date share price return down 32.54%. The 1 day share price return of 6.66% alongside a 7 day share price return...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

Is Grand Canyon Education (LOPE) Cheap Following Its Recent Share Price Slide?

Grand Canyon Education (LOPE) has drawn investor attention after a period of mixed share performance, with the stock down over the past week, month, past 3 months, and in the year to date. See our latest analysis for Grand Canyon Education. With the share price at US$140.44 and the 90 day share price return down 19.71%, recent weakness follows a softer year to date pattern. However, the 3 year total shareholder return of 28.73% and 5 year total shareholder return of 52.49% still reflect a...
NYSE:CIEN
NYSE:CIENCommunications

Is Ciena (CIEN) Priced For Growth Or Cash Flow Value?

Ciena stock has delivered a very large three year gain of roughly 7.8x, yet the company now sits in an unusual valuation split where the Discounted Cash Flow (DCF) intrinsic value estimate points to meaningful upside while earnings based multiples suggest the shares are expensive compared with peers. Over the past three years, Ciena has returned roughly 7.8x, so the current debate centers on how much of the company’s potential is already reflected in the price. Progress in quantum safe data...
NYSE:FDX
NYSE:FDXLogistics

FedEx (FDX) On Freight Spin And Cost Cuts With Fair Value Still In View

Why FedEx’s debt tender and Freight spin are in focus now FedEx (FDX) is back in the spotlight after a large cash tender offer for its long dated notes coincided with fresh analyst commentary on its Freight spin off and new operating plans. Together, the US$4.2b tender cap and the Freight separation are shaping how investors think about FedEx’s capital structure, cost savings and execution risks, particularly as opinions differ on margins and on the timing of its transformation efforts. See...
NYSE:PM
NYSE:PMTobacco

Philip Morris International (PM) Could Be 10% Undervalued Following The ZYN FDA Decision

The FDA’s authorization of ZYN nicotine pouches as modified risk tobacco products puts Philip Morris International (NYSE:PM) in the spotlight, as investors weigh what this new regulatory status could mean for the stock. See our latest analysis for Philip Morris International. The ZYN ruling lands at a time when Philip Morris International’s share price has gained 22.30% over the past 90 days and 20.39% year to date. The 3 year total shareholder return of 125.02% and 5 year total shareholder...
NasdaqGS:ACIW
NasdaqGS:ACIWSoftware

ACI Worldwide (ACIW) Stock Looks Cheap On Cash Flow While Earnings Look Fair

ACI Worldwide stock has surged over the past three years, yet the valuation picture is mixed, with the intrinsic value estimate from a Discounted Cash Flow (DCF) model suggesting the shares trade below that estimate while the broader checks still do not flag the stock as a clear bargain. ACI Worldwide has returned 150.3% over the past three years, which puts extra focus on whether the current price still leaves room above intrinsic value or mainly reflects past gains. Recent news...
NYSE:GM
NYSE:GMAuto

General Motors Stock And 2 US Auto Makers Built For Tariff Pressure

The tariff clock is ticking for U.S. auto manufacturers, and the expiry of President Trump's temporary 10% global tariff has put fresh attention on which stocks may be positioned to cope with the next round of trade policy changes. With new, potentially more permanent duties on the horizon, investors are reassessing how global supply chains, import exposure, and cost structures could affect returns. This article walks through three stocks from a U.S. domestic auto manufacturers screener that...
NYSE:BNY
NYSE:BNYCapital Markets

BNY (BNY) Stock Could Be 15% Overvalued Despite Record Earnings

After a very strong three year share price run of 277.6%, Bank of New York Mellon Corporation now faces a valuation debate, with its intrinsic value estimate from the Excess Returns model pointing to the stock trading at a premium, while market multiples suggest pricing that is closer to about right. BNY has delivered a very large 277.6% total return over three years, which means a lot of optimism is already reflected in the share price. Recent earnings momentum, supported by fees, interest...
NYSE:VLO
NYSE:VLOOil and Gas

Valero Energy (VLO) Following Record Refining Margins Is The Stock Already Fully Valued

Valero Energy (VLO) is back in focus after its board affirmed a regular quarterly cash dividend of $1.20 per share, a decision arriving as refiners benefit from record fuel refining margins. See our latest analysis for Valero Energy. The recent dividend announcement comes as Valero Energy’s share price has strong momentum, with a 30 day share price return of 29.14% and an 87.31% year to date share price return. This has contributed to a 117.29% 1 year total shareholder return and a very large...
NasdaqGS:MPWR
NasdaqGS:MPWRSemiconductor

Monolithic Power Systems (MPWR) Stock Looks Stretched Following Its 228% Five Year Run

Monolithic Power Systems stock has delivered very strong gains over the past few years, yet the latest valuation checks suggest the shares now lean expensive rather than like a clear bargain. Over the last 5 years, Monolithic Power Systems has returned 228.4%, which puts recent share price weakness into context as a pullback after a long period of strong compounding. Expectations around AI related demand in data and communications can support a rich valuation, while ongoing legal and...
NYSE:FIX
NYSE:FIXConstruction

Comfort Systems USA (FIX) Stock May Trade At A 36% Discount After AI Infrastructure News

Comfort Systems USA has been on a remarkable run over the past few years, yet at around US$1,674 per share the stock still screens as undervalued on both an intrinsic value estimate using a Discounted Cash Flow (DCF) approach and on market multiples. That sets up a clear tension for investors, with very strong long term returns on one side and valuation tools suggesting the current price may still sit below intrinsic value. Over the past 5 years, Comfort Systems USA has delivered a very...
NasdaqGS:OUST
NasdaqGS:OUSTElectronic

Ouster (OUST) Updates EBITDA Breakeven Plan On A Valuation Narrative Still In Question

Ouster (OUST) recently updated investors on its financial roadmap, highlighting a focus on reaching EBITDA breakeven supported by efforts in revenue growth, product development across its lidar portfolio, and wider adoption in automotive, industrial, and smart infrastructure markets. See our latest analysis for Ouster. The recent EBITDA breakeven update comes after a mixed share price run, with Ouster’s 1 day share price return of 5.41% contrasting with a 7 day decline of 14.42%, a 30 day...
NYSE:SCHW
NYSE:SCHWCapital Markets

Charles Schwab (SCHW) On Rising Earnings Confidence And Platform Upgrades Looks Undervalued

Growing analyst confidence around upcoming earnings, combined with Charles Schwab (SCHW) platform upgrades and strong client retention data, has pushed the stock further into focus for investors watching the June quarter. See our latest analysis for Charles Schwab. Recent trading reflects that confidence, with the share price at about $101.56 after a 30 day share price return of 7.46% and a 90 day share price return of 10.06%. A 1 year total shareholder return of 7.36% and 3 year total...
NasdaqGS:CRWD
NasdaqGS:CRWDSoftware

Is CrowdStrike (CRWD) Using EU-Sovereign AI Security Deals To Recast Its Competitive Identity Moat?

CrowdStrike and Schwarz Digits recently expanded their partnership to deliver the AI-native Falcon cybersecurity platform on STACKIT, a sovereign EU cloud, while CrowdStrike also agreed to acquire XM Cyber’s intellectual property and appointed former Splunk Security executive AJ Shipley as Chief Product Officer. These moves, alongside Frost & Sullivan naming CrowdStrike the 2026 Global Company of the Year in Identity Threat Detection and Response, highlight the company’s push to anchor...
NasdaqCM:ESQ
NasdaqCM:ESQBanks

Is Esquire Financial (ESQ) Pre‑Earnings Trading Hinting At A Shift In Its Growth Narrative?

Earlier this week, Esquire Financial Holdings saw heightened trading activity as investors focused on its upcoming second-quarter earnings release and anticipated year-over-year growth in earnings and revenue. The unchanged consensus EPS estimate over the past month, despite this optimism, suggests analysts are waiting for actual results before revising their expectations. Next, we’ll explore how this pre-earnings optimism, reflected in stronger trading interest, could influence Esquire...
NasdaqGS:MRNA
NasdaqGS:MRNABiotechs

Does Moderna’s (MRNA) New mRNA-4200 Trial Quietly Rebalance Its Long-Term Oncology Risk Profile?

Earlier this month, Moderna announced it had dosed the first U.S. participant in a Phase 1 trial of mRNA-4200, an mRNA-based, tumor-targeted cancer antigen therapy being tested with checkpoint inhibitor treatment in adults with advanced solid tumors under its collaboration with Immatics. This early-stage oncology milestone underscores Moderna’s effort to extend its mRNA platform beyond infectious diseases into cancer, adding a new dimension to how investors may think about the company’s...
NYSE:CXW
NYSE:CXWCommercial Services

CoreCivic (CXW) Could Be 16% Undervalued After Redeeming Its 2027 Notes

CoreCivic (CXW) has moved to redeem all remaining 4.750% senior notes due 2027, a US$238.5m balance, effective August 12, 2026, using cash on hand, drawing attention to the company’s capital structure. See our latest analysis for CoreCivic. CoreCivic’s decision to fully redeem its 2027 notes comes after a strong run in the stock, with a 30 day share price return of 8.8% and a 90 day gain of 49.9%, while the 3 year total shareholder return of 233.2% points to powerful longer term momentum. If...
NasdaqGS:RIVN
NasdaqGS:RIVNAuto

Rivian (RIVN) Stock May Be Overvalued Even As Sales Stay Strong

Rivian Automotive’s share price has swung between sharp setbacks and rebounds over the past few years, and with the stock recently around US$17.46, the core question for investors is whether that price still looks rich given a weak overall value score and mixed sentiment around its capital needs. Over the past 3 years the stock has declined about 30.9%, which suggests investors who bought early are still facing a material drawdown despite more recent strength. On the one hand, expectations...
NYSE:AGL
NYSE:AGLHealthcare

agilon Health (AGL) Stock Looks Undervalued On Sales But Rich After A 7x Run

After a very strong year to date move, agilon health now looks like a stock where price momentum and a supportive valuation score are pulling in the same direction. This raises the question of how much of the recent enthusiasm is already reflected in the share price. Year to date, agilon health has returned a very large 671%, which puts recent price action front and center in any valuation discussion. Recent news that its REACH Accountable Care Organizations generated US$229m in gross...
NYSE:AMC
NYSE:AMCEntertainment

AMC (AMC) Stock Trades At A Discount On Its 99% Five Year Slump

AMC Entertainment Holdings stock now trades around US$1.94 after a long slide in which shareholders have seen the value of their investment fall about 99% over five years, while some valuation checks still suggest the shares are not clearly expensive on current metrics. Over the past five years, AMC Entertainment Holdings has declined about 99%, which means any fresh move in the share price carries outsized importance for existing holders. Recent balance sheet moves to refinance high...
NasdaqGS:PEBO
NasdaqGS:PEBOBanks

Peoples Bancorp (PEBO) Stock Looks Cheap Relative To Fair Value

Peoples Bancorp stock has delivered a 77.3% return over the past 5 years. At a last close of US$39.39, the Excess Returns intrinsic value estimate still points to meaningful upside, while the market multiples suggest the shares are priced roughly in line with peers. Over 5 years, a 77.3% total return suggests the market has already repriced Peoples Bancorp materially higher, so the easy gains may be behind it. Future profitability and loan growth can support the current valuation, but...
NYSE:LPG
NYSE:LPGOil and Gas

Will Dorian LPG’s (LPG) US$1 Irregular Dividend and Asset Sale Shift Its Capital-Return Narrative?

Dorian LPG Ltd. recently declared an irregular US$1.00 per-share cash dividend, returning about US$42.8 million to shareholders, following the earlier sale of its 2014-built VLGC Corsair for roughly US$81.8 million and repayment of US$24.2 million of associated debt in the quarter ended June 30, 2026. Together, the special dividend and vessel sale highlight Dorian LPG’s use of asset recycling and excess liquidity to return capital while reshaping its fleet profile. We’ll now examine how this...
NYSE:PLD
NYSE:PLDIndustrial REITs

Prologis (PLD) Stock Faces Rich Valuation As One Off Gain Skews Earnings Narratives

Prologis (PLD) kicked off its Q2 2026 update with revenue of about US$2.4 billion and basic EPS of roughly US$1.11 for the quarter, alongside trailing twelve month earnings growth of 22.1% and a net margin of 43.8%. Over the past six quarters, the company has seen revenue move from about US$2.21 billion in Q1 2025 to roughly US$2.43 billion in Q2 2026, with trailing twelve month revenue reaching about US$9.6 billion and basic EPS of around US$4.52. For investors, the combination of higher...